ISCHSTR
MCID: STR067
MIFTS: 75

Stroke, Ischemic (ISCHSTR) malady

Categories: Genetic diseases, Cardiovascular diseases, Neuronal diseases

Aliases & Classifications for Stroke, Ischemic

Summaries for Stroke, Ischemic

MedlinePlus : 41 a stroke is a medical emergency. strokes happen when blood flow to your brain stops. within minutes, brain cells begin to die. there are two kinds of stroke. the more common kind, called ischemic stroke, is caused by a blood clot that blocks or plugs a blood vessel in the brain. the other kind, called hemorrhagic stroke, is caused by a blood vessel that breaks and bleeds into the brain. "mini-strokes" or transient ischemic attacks (tias), occur when the blood supply to the brain is briefly interrupted. symptoms of stroke are sudden numbness or weakness of the face, arm or leg (especially on one side of the body) sudden confusion, trouble speaking or understanding speech sudden trouble seeing in one or both eyes sudden trouble walking, dizziness, loss of balance or coordination sudden severe headache with no known cause if you have any of these symptoms, you must get to a hospital quickly to begin treatment. acute stroke therapies try to stop a stroke while it is happening by quickly dissolving the blood clot or by stopping the bleeding. post-stroke rehabilitation helps individuals overcome disabilities that result from stroke damage. drug therapy with blood thinners is the most common treatment for stroke. nih: national institute of neurological disorders and stroke

MalaCards based summary : Stroke, Ischemic, also known as cerebral infarction, is related to myocardial infarction and ischemic optic neuropathy, and has symptoms including stroke, angina pectoris and back pain. An important gene associated with Stroke, Ischemic is F5 (Coagulation Factor V), and among its related pathways/superpathways are Response to elevated platelet cytosolic Ca2+ and Collagen chain trimerization. The drugs Benzocaine and Nimodipine have been mentioned in the context of this disorder. Affiliated tissues include Bone and Umbilical Cord, and related phenotypes are homeostasis/metabolism and cardiovascular system

OMIM : 54 A stroke is an acute neurologic event leading to death of neural tissue of the brain and resulting in loss of motor,... (601367) more...

CDC : 3 Learn what you can do to prevent stroke.

NINDS : 51 A stroke occurs when the blood supply to part of the brain is suddenly interrupted or when a blood vessel in the brain bursts, spilling blood into the spaces surrounding brain cells. Brain cells die when they no longer receive oxygen and nutrients from the blood or there is sudden bleeding into or around the brain. The symptoms of a stroke include sudden numbness or weakness, especially on one side of the body; sudden confusion or trouble speaking or understanding speech; sudden trouble seeing in one or both eyes; sudden trouble with walking, dizziness, or loss of balance or coordination; or sudden severe headache with no known cause. There are two forms of stroke:  - blockage of a blood vessel supplying the brain, and  - bleeding into or around the brain.

UniProtKB/Swiss-Prot : 66 Ischemic stroke: A stroke is an acute neurologic event leading to death of neural tissue of the brain and resulting in loss of motor, sensory and/or cognitive function. Ischemic strokes, resulting from vascular occlusion, is considered to be a highly complex disease consisting of a group of heterogeneous disorders with multiple genetic and environmental risk factors.

Related Diseases for Stroke, Ischemic

Diseases related to Stroke, Ischemic via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 203)
id Related Disease Score Top Affiliating Genes
1 myocardial infarction 30.5 ACE ALOX5AP CRP F2 F3 F5
2 ischemic optic neuropathy 29.6 ACE APOH CRP F2 SELP SERPINC1
3 mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes 12.3
4 pediatric arterial ischemic stroke 12.2
5 autosomal recessive leukoencephalopathy with ischemic stroke-retinitis pigmentosa syndrome 12.0
6 sneddon syndrome 11.9
7 cerebrovascular disease 11.6
8 neonatal stroke 11.3
9 intracranial embolism 11.2
10 brain ischemia 11.1
11 cortical blindness 11.0
12 polyarteritis nodosa, childhood-onset 11.0
13 aspiration pneumonitis 11.0
14 cadasil 2 10.8
15 moyamoya 6 with achalasia 10.8
16 cadasil 10.8
17 brain small vessel disease with or without ocular anomalies 10.8
18 angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps 10.8
19 cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 10.8
20 col4a1-related brain small-vessel disease 10.8
21 cerebritis 10.5
22 med13l syndrome 10.5 APOH F5
23 multiple familial trichoepithelioma 10.5 F5 MTHFR
24 absence of innominate vein 10.5 F5 MTHFR SERPINE1
25 aminoaciduria 10.5 F5 MTHFR SERPINE1
26 lung cancer 10.5 APOH F5 MTHFR
27 stt3a-cdg and stt3b-cdg 10.5 F5 SERPINC1 SERPINE1
28 photosensitive epilepsy 10.5 F2 F5 MTHFR
29 peanut allergy 10.4 F2 PLAT SERPINC1
30 congenital insensitivity to pain with severe intellectual disability 10.4 F2 F5
31 mixed epithelial tumor of ovary 10.4 F2 MTHFR SERPINC1
32 influenza 10.4 F2 F3 SERPINC1
33 freiberg's disease 10.4 F2 F3 SERPINC1
34 may-hegglin anomaly 10.4 APOH F2 SERPINC1
35 kartagener syndrome 10.4 ACE MTHFR NOS3
36 myosclerosis, congenital 10.4 F5 MTHFR SERPINC1
37 chorioretinal scar 10.4 F2 F3 SERPINC1
38 brazilian hemorrhagic fever 10.4 PLAT SERPINC1 SERPINE1
39 mixed hepatoblastoma 10.4 F2 F3 SERPINC1
40 alpha-2-macroglobulin deficiency 10.4 F2 F3 VWF
41 supraumbilical midabdominal raphe and facial cavernous hemangiomas 10.4 APOH F2 F5 MTHFR
42 dmd-related dilated cardiomyopathy 10.4 F2 F3 SERPINC1
43 periosteal chondrosarcoma 10.4 F2 SERPINC1 SERPINE1
44 hereditary endotheliopathy, retinopathy, nephropathy, and stroke 10.4 F3 SELP SERPINC1
45 urogenital adysplasia 10.4 THBD VWF
46 achard thiers syndrome 10.4 APOH F5
47 hendra virus infection 10.4 APOH F2 F3 F5
48 inherited blood coagulation disease 10.4 F3 F5 SERPINE1
49 microphthalmia, isolated, with coloboma 10 10.4 F5 SELP SERPINE1
50 melorheostosis 10.4 ACE PLAT SERPINC1

Graphical network of the top 20 diseases related to Stroke, Ischemic:



Diseases related to Stroke, Ischemic

Symptoms & Phenotypes for Stroke, Ischemic

Symptoms by clinical synopsis from OMIM:

601367

Clinical features from OMIM:

601367

Human phenotypes related to Stroke, Ischemic:

32
id Description HPO Frequency HPO Source Accession
1 stroke 32 HP:0001297

UMLS symptoms related to Stroke, Ischemic:


angina pectoris, back pain, chest pain, edema, headache, pain, sciatica, seizures, syncope, tremor, chronic pain, vertigo/dizziness, equilibration disorder, sleeplessness

MGI Mouse Phenotypes related to Stroke, Ischemic:

44 (show all 12)
id Description MGI Source Accession Score Top Affiliating Genes
1 homeostasis/metabolism MP:0005376 10.41 F3 F5 MTHFR NOS3 NOTCH3 PLAT
2 cardiovascular system MP:0005385 10.36 ACE CRP F2 F3 F5 NOS3
3 hematopoietic system MP:0005397 10.29 SERPINE1 THBD VWF ACE ALOX5AP F2
4 immune system MP:0005387 10.28 CRP F2 F3 NOS3 NOTCH3 PLAT
5 growth/size/body region MP:0005378 10.27 ACE F2 F3 F5 MTHFR NOS3
6 mortality/aging MP:0010768 10.2 NOS3 NOTCH3 PLAT PRKCH SELP SERPINC1
7 integument MP:0010771 10.06 F2 F3 F5 MTHFR NOTCH3 PRKCH
8 nervous system MP:0003631 10 F2 F3 F5 MTHFR NOS3 NOTCH3
9 liver/biliary system MP:0005370 9.91 ACE F5 NOS3 SELP SERPINC1 SERPINE1
10 renal/urinary system MP:0005367 9.76 ACE NOS3 NOTCH3 PTGIS SELP SERPINC1
11 respiratory system MP:0005388 9.56 NOS3 NOTCH3 PLAT SELP SERPINE1 THBD
12 vision/eye MP:0005391 9.23 F3 MTHFR NOS3 NOTCH3 PLAT PRKCH

Drugs & Therapeutics for Stroke, Ischemic

Drugs for Stroke, Ischemic (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 1032)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Benzocaine Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 1994-09-7, 94-09-7 2337
2
Nimodipine Approved Phase 4,Phase 2,Phase 1 66085-59-4 4497
3
Ticlopidine Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 55142-85-3 5472
4
Menthol Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 2216-51-5 16666
5
Valsartan Approved, Investigational Phase 4,Phase 3,Phase 2 137862-53-4 60846
6
Heparin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 9005-49-6 772 46507594
7 Nadroparin Approved Phase 4 9041-08-1
8
Atenolol Approved Phase 4,Phase 3 29122-68-7 2249
9
Zinc Approved Phase 4,Phase 2,Phase 3,Phase 1 7440-66-6 32051 23994
10
Aspirin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 50-78-2 2244
11
Candesartan Approved Phase 4,Phase 3 139481-59-7 2541
12
Citalopram Approved Phase 4,Phase 3,Phase 2,Phase 1 59729-33-8 2771
13
Nicardipine Approved Phase 4,Phase 3,Phase 1 55985-32-5 4474
14
Acenocoumarol Approved Phase 4,Phase 3,Phase 2 152-72-7 9052 54676537
15
Salicylic acid Approved, Vet_approved Phase 4,Phase 3 69-72-7 338
16
Norepinephrine Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 51-41-2 439260
17
Reboxetine Approved, Investigational Phase 4 98769-81-4, 71620-89-8 123628 65856
18
Acetylcholine Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 51-84-3 187
19
Colchicine Approved Phase 4,Phase 3 64-86-8 6167 2833
20
Dopamine Approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 51-61-6, 62-31-7 681
21
Memantine Approved, Investigational Phase 4,Phase 3,Early Phase 1 19982-08-2 4054
22
Indapamide Approved Phase 4,Phase 3 26807-65-8 3702
23
Perindopril Approved Phase 4,Phase 3 107133-36-8, 82834-16-0 107807
24
Phenprocoumon Approved Phase 4,Phase 3 435-97-2 9908 54680692
25
Warfarin Approved Phase 4,Phase 2,Phase 3,Phase 1 81-81-2 6691 54678486
26
Bivalirudin Approved, Investigational Phase 4,Phase 3,Phase 2 128270-60-0 16129704
27
Etanercept Approved, Investigational Phase 4,Phase 1,Phase 2 185243-69-0
28
Rivastigmine Approved, Investigational Phase 4,Phase 3 123441-03-2 77991
29
Amlodipine Approved Phase 4,Phase 3,Phase 2,Phase 1 88150-42-9 2162
30
Clonidine Approved Phase 4,Phase 3 4205-90-7 2803
31
Doxazosin Approved Phase 4 74191-85-8 3157
32
Furosemide Approved, Vet_approved Phase 4,Phase 3 54-31-9 3440
33
Hydrochlorothiazide Approved, Vet_approved Phase 4,Phase 3,Phase 2 58-93-5 3639
34
Irbesartan Approved, Investigational Phase 4,Phase 3 138402-11-6 3749
35
Ramipril Approved Phase 4,Phase 3,Phase 2 87333-19-5 5362129
36
Simvastatin Approved Phase 4,Phase 2,Phase 3,Early Phase 1 79902-63-9 54454
37
Amiloride Approved Phase 4,Phase 3 2016-88-8, 2609-46-3 16231
38
Telmisartan Approved, Investigational Phase 4,Phase 2 144701-48-4 65999
39
Acarbose Approved, Investigational Phase 4,Phase 3,Phase 2 56180-94-0 441184
40
Pravastatin Approved Phase 4,Phase 3,Phase 2 81093-37-0 54687
41
Ticagrelor Approved Phase 4,Phase 3,Phase 2,Phase 1 274693-27-5 9871419
42
Rivaroxaban Approved Phase 4,Phase 2,Phase 3 366789-02-8
43
Glyburide Approved Phase 4,Phase 3,Phase 2,Phase 1 10238-21-8 3488
44
Metformin Approved Phase 4,Phase 3 657-24-9 14219 4091
45
Vildagliptin Approved, Investigational Phase 4 274901-16-5 6918537
46
Methyldopa Approved Phase 4 555-30-6 38853
47
Esomeprazole Approved, Investigational Phase 4,Phase 3 161796-78-7, 119141-88-7 4594 9579578
48
Pantoprazole Approved Phase 4,Phase 3,Phase 2 102625-70-7 4679
49
Rabeprazole Approved, Investigational Phase 4,Phase 3 117976-89-3 5029
50
Everolimus Approved Phase 4,Phase 3,Phase 2,Phase 1 159351-69-6 6442177

Interventional clinical trials:

(show top 50) (show all 5960)
id Name Status NCT ID Phase
1 Nimodipine for Treating Acute Massive Cerebral Infarction Unknown status NCT02248233 Phase 4
2 The Effect of Erigeron Injection on Acute Cerebral Infarction Serum VEGF, MMP-9 and EPC Levels Unknown status NCT01926834 Phase 4
3 The Dynamic Effect of Non-cytochrome P450 Isoenzyme 3A4(CYP3A4)-Metabolized and Cytochrome P450 Isoenzyme 3A4(CYP3A4)-Metabolized Statins on Clopidogrel Resistance in Patients With Cerebral Infarction Unknown status NCT02411903 Phase 4
4 A Randomized Double Blind Placebo Control Study of Huang-Chi-Wu-Wu- Tang in Patients With Intracranial Arterial Stenosis Unknown status NCT01553643 Phase 4
5 Efficacy and Safety Study of Nimodipine to Prevent Mild Cognitive Impairment After Acute Ischemic Strokes Unknown status NCT01220622 Phase 4
6 Valsartan Efficacy on Modest Blood Pressure Reduction in Acute Ischemic Stroke Unknown status NCT00874601 Phase 4
7 Safety and Efficacy of Heparin and Nadroparin in the Acute Phase of Ischemic Stroke Unknown status NCT01862978 Phase 4
8 Delayed Vasospasm After Aneurysm With the Standardization Treatment of Traditional Chinese Medicine Unknown status NCT01840761 Phase 4
9 A Clinical Trial of Danhong Injection in Treating Acute Ischemic Stroke Unknown status NCT02152280 Phase 4
10 Comparison of Peripheral and Cerebral Arterial Flow in Acute Ischemic Stroke: Fimasartan vs. Valsartan vs. Atenolol Unknown status NCT02403349 Phase 4
11 Efficacy Study of Huatuo Zaizao Pills in Improving of Neural Function in Acute Ischemic Stroke Unknown status NCT01758536 Phase 4
12 Comparison of Two Strategies for Glycemic Control in Acute Ischemic Stroke Unknown status NCT00747279 Phase 4
13 Partial Oral Treatment of Endocarditis Unknown status NCT01375257 Phase 4
14 Cerebral Artery Stenosis, Coronary Artery Disease and Arrhythmia Unknown status NCT00247533 Phase 4
15 Coronary Angioplasty in Octogenarians With Emergent Coronary Syndromes Unknown status NCT02126202 Phase 4
16 IRIS : Use of Implantable Defibrillator in High-Risk Patients Early After Acute Myocardial Infarction Unknown status NCT00157768 Phase 4
17 Normoglycemia and Neurological Outcome Unknown status NCT01137773 Phase 4
18 Japanese Primary Prevention Project With Aspirin Unknown status NCT00225849 Phase 4
19 Effects of Intensive Statin Treatment on Left Ventricular Function Unknown status NCT01936103 Phase 4
20 Atrial Fibrillation and the Risk for Neurological Complications Unknown status NCT00357227 Phase 4
21 The Effectiveness and Safety of Butylphthalide Soft Capsules in Secondary Prevention of Ischemic Stroke Trial Unknown status NCT00724724 Phase 4
22 Effects of Levothyroxine Supplementation in Patients With Systolic Heart Failure and Subclinical Hypothyroidism Unknown status NCT02316743 Phase 4
23 4-point vs 4-roll Canne as Walking Aids After Stroke Unknown status NCT02279069 Phase 4
24 Acute Candesartan Cilexetil Outcomes Stroke Trial (ACCOST) Unknown status NCT00108706 Phase 4
25 Multi-"Omics" Research of Danhong Injection to Treat Acute Ischemic Stroke Unknown status NCT02176395 Phase 4
26 Effects on Clinical and Functional Outcome of Escitalopram in Adult Stroke Patients Unknown status NCT00967408 Phase 4
27 Creative Therapy to Affect Stroke Outcomes Unknown status NCT01455155 Phase 4
28 Study of Stroke Volume Variation and Pleth Variability Index as Predictors of Fluid Responsiveness Unknown status NCT02122367 Phase 4
29 Functional Electrical Stimulation (FES) Assisted Walking: Enhancement of Walking Function After Stroke Unknown status NCT00552916 Phase 4
30 Device Closure Versus Medical Therapy for Cryptogenic Stroke Patients With High-Risk Patent Foramen Ovale (DEFENSE-PFO) Unknown status NCT01550588 Phase 4
31 The Outcomes of Seamless ADL Training Between Occupational Therapist and Nurse in Stroke Patients Unknown status NCT02361307 Phase 4
32 Safety Study of Melatonin in Stroke Patients Unknown status NCT01863277 Phase 4
33 The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients Unknown status NCT01278498 Phase 4
34 IV Double and Triple Concentrated Nicardipine for Stroke and ICH Unknown status NCT00325793 Phase 4
35 Randomized, Double Blind, Placebo Control Trial to Evaluate the Efficacy of Astragalus Membranaceus in the Patients After Stroke With Fatigue Unknown status NCT01554787 Phase 4
36 FINGER Robot Therapy Study Unknown status NCT02048826 Phase 4
37 Anticoagulation in Stent Intervention Unknown status NCT01141153 Phase 4
38 Antispastic Effect of Transcranial Magnetic Stimulation in Patients With Cerebral and Spinal Spasticity Unknown status NCT01786005 Phase 4
39 Enhancement of Motor Function With Reboxetine and Transcranial Direct Current Stimulation Unknown status NCT00853866 Phase 4
40 A Trial to Evaluate Efficacy of Heart-protecting Musk Pill Unknown status NCT01897805 Phase 4
41 Upper Extremity Rehabilitation Using Robot and Botulinum Toxin Unknown status NCT02228863 Phase 4
42 Colchicine for Acute Coronary Syndromes Unknown status NCT01906749 Phase 4
43 Memantine and Constraint-Induced Language Therapy in Chronic Poststroke Aphasia:A Randomized Controlled Trial Unknown status NCT00196703 Phase 4
44 The Hypertension in the Very Elderly Trial (HYVET) Unknown status NCT00122811 Phase 4
45 Early Warning and Optimization Strategy in Carotid Endarterectomy Unknown status NCT01210937 Phase 4
46 HOPE-2 Study (Heart Outcomes Prevention Evaluation-2 Study) Unknown status NCT00106886 Phase 4
47 Aspirin Resistance and Prognosis of Patients With Critical Limb Ischaemia Unknown status NCT01104441 Phase 4
48 Triple Therapy in Patients on Oral Anticoagulation After Drug Eluting Stent Implantation Unknown status NCT00776633 Phase 4
49 Aspirin in the Prevention of Cardiovascular Events in Hemodialysis Patients Unknown status NCT01198379 Phase 4
50 SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy Unknown status NCT00403078 Phase 4

Search NIH Clinical Center for Stroke, Ischemic

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cell-based therapeutics:


LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database
Read about Stroke, Ischemic cell therapies at LifeMap Discovery.
Stem-cell-based therapeutic approaches for Stroke, Ischemic:
ALD-401, bone marrow-derived cells for stroke
Autologous bone marrow-derived mononuclear cells for treatment of acute ischemic stroke
Bone marrow-derived mononuclear cells for ischemic stroke
Bone marrow-derived mononuclear cells for ischemic stroke
Cerecellgram-Stroke, bone marrow-derived mesenchymal stem cells for treatment of ischemic stroke
Embryonic stem cell-derived neural stem cells for ischemic stroke
Mesenchymal stem cells for ischemic stroke
MultiStem
NSI-566, spinal cord stem cells for neurological disorders
Olfactory ensheathing cells transplantion for treatment of old stroke ischemic patients
PDA001, Placenta-derived cells for ischemic stroke
ReN001, human neural stem cells for the treatment of stroke
SB623, Notch1-transfected mesenchymal stem cells for stroke
Stemedyne
Umbilical cord blood-derived CD34+ stem cells for treatment of chronic ischemic stroke
Umbilical cord-derived mesenchymal stem cells for treatment of stroke
Embryonic/Adult Cultured Cells Related to Stroke, Ischemic:
Bone marrow-derived ALDH+ cells (ALD) PMIDs: 10430905
Bone marrow-derived mononuclear cells (family) PMIDs: 22960888
Bone marrow-derived mononuclear cells PMIDs: 17635049
Bone marrow-derived mononuclear cells PMIDs: 20629187 20395386
Bone marrow-derived mesenchymal stem cells (Cerecellgram-Stroke)
Neural stem cells PMIDs: 18286199
Bone marrow-derived mesenchymal stem cells (family)
Bone marrow-derived adherent progenitor cells (MultiStem) PMIDs: 22952736 21175285
Fetal spinal cord stem cells (NSI-566) PMIDs: 22415942 19326469
Olfactory ensheathing cells
Placenta-derived cells
Neural stem cell line (CTX0E03) PMIDs: 19633272 23185625 17981710
Notch-transfected mesenchymal stromal cells (SB623) PMIDs: 19530164 23430693 20350349 21982515
Trophic factor-induced mesenchymal stem cells PMIDs: 19530164 23430693 20350349 21982515
Bone marrow-derived mesenchymal stem cells (Stemedyne PMIDs: 23295150
Umbilical cord blood-derived hematopoietic stem cells (family)
Umbilical cord-derived mesenchymal stem cells

Cochrane evidence based reviews: cerebral infarction

Genetic Tests for Stroke, Ischemic

Genetic tests related to Stroke, Ischemic:

id Genetic test Affiliating Genes
1 Ischemic Stroke 29
2 Stroke 29

Anatomical Context for Stroke, Ischemic

MalaCards organs/tissues related to Stroke, Ischemic:

39
Brain, Bone, Eye, Bone Marrow, Spinal Cord, Lung, Breast
LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database

Cells/anatomical compartments in embryo or adult related to Stroke, Ischemic:
id Tissue Anatomical CompartmentCell Relevance
1 Bone Bone Marrow Bone Marrow Stromal Cells Potential therapeutic candidate
2 Umbilical Cord Wharton's Jelly Mesenchymal Stem Cells

Publications for Stroke, Ischemic

Articles related to Stroke, Ischemic:

id Title Authors Year
1
Associations between hematopoietic growth factors and risks of venous thromboembolism, stroke, ischemic heart disease and myelodysplastic syndrome: findings from a large population-based cohort of women with breast cancer. ( 27059219 )
2016
2
Glycated hemoglobin and risk of stroke, ischemic and hemorrhagic, in Japanese men and women. ( 18667812 )
2008